These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8769708)

  • 41. Allogeneic stem cell transplantation for chronic myeloid leukemia.
    Barrett J
    Semin Hematol; 2003 Jan; 40(1):59-71. PubMed ID: 12563612
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Autogeneic peripheral blood hemopoietic stem cell transplantation for chronic myeloid leukemia with imatinib mesylate-induced negative Philadelphia chromosome].
    Meng FY; Sun J; Liu QF; Xu D; Yang LJ; Song LL; Liu XL; Xu B; Zhou SY
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1301-2, 1306. PubMed ID: 14678896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interferon alpha in the treatment of chronic myelogenous leukemia.
    Robak T
    Arch Immunol Ther Exp (Warsz); 1998; 46(6):347-53. PubMed ID: 9883313
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The graft-versus-leukemia effect of nonmyeloablative stem cell allografts may not be sufficient to cure chronic myelogenous leukemia.
    Sloand E; Childs RW; Solomon S; Greene A; Young NS; Barrett AJ
    Bone Marrow Transplant; 2003 Nov; 32(9):897-901. PubMed ID: 14561990
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data.
    Kantarjian HM; O'Brien S; Cortes J; Giles FJ; Rios MB; Shan J; Faderl S; Garcia-Manero G; Ferrajoli A; Verstovsek S; Wierda W; Keating M; Talpaz M
    Cancer; 2003 Dec; 98(12):2636-42. PubMed ID: 14669283
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autologous hematopoietic cell transplantation for chronic myelogenous leukemia.
    Bhatia R; McGlave PB
    Hematol Oncol Clin North Am; 2004 Jun; 18(3):715-32, xi. PubMed ID: 15271402
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Eradication of the Philadelphia chromosome-positive clone and persistent restoration of normal polyclonal haemopoiesis in a chronic myelogenous leukemia patient after autologous transplant with peripheral blood Philadelphia-negative haemopoietic cells.
    Carella AM; Frassoni F; Podesta M; Saglio G
    Bone Marrow Transplant; 1994 May; 13(5):668-9. PubMed ID: 7914449
    [No Abstract]   [Full Text] [Related]  

  • 48. Relapse of chronic myeloid leukemia (CML) in lymphoid crisis after allogeneic bone marrow transplantation for CML in chronic phase with busulfan plus cyclophosphamide regimen.
    Takami A; Chuhjo T; Nakao S
    Haematologica; 2002 Jun; 87(6):659-61. PubMed ID: 12031925
    [No Abstract]   [Full Text] [Related]  

  • 49. Autografting in chronic myeloid leukemia: an overview.
    Reiffers J; Mahon FX; Boiron JM; Fabères C; Marit G; Cony-Makhoul P; Broustet A
    Leukemia; 1996 Mar; 10(3):385-8. PubMed ID: 8642851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Karyotypic conversion by interferon as preparative treatment for autologous BMT in Ph positive CML. Italian Cooperative Study Group (ICSG) on Chronic Myeloid Leukemia.
    Leuk Lymphoma; 1993; 11 Suppl 1():277-80. PubMed ID: 8251909
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Progress in the field of hematology in the last 100 years: Medical history of chronic myelogenous leukemia].
    Tomonaga M
    Nihon Naika Gakkai Zasshi; 2002 Jul; 91(7):2090-4. PubMed ID: 12187683
    [No Abstract]   [Full Text] [Related]  

  • 52. [Malignant and premalignant processes of myeloid systems. Guidelines of the Professional College of Hematology].
    Orv Hetil; 1994 Dec; 135(50):2775-6. PubMed ID: 7838512
    [No Abstract]   [Full Text] [Related]  

  • 53. Interferon alfa and low-dose cytosine-arabinoside for the treatment of patients with chronic myelogenous leukemia in chronic phase. French CML Study Group.
    Guilhot F
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):24-5. PubMed ID: 8235700
    [No Abstract]   [Full Text] [Related]  

  • 54. Autografting for chronic myelocytic leukemia.
    McGlave P
    Bone Marrow Transplant; 1994; 14 Suppl 3():S49-50. PubMed ID: 7697008
    [No Abstract]   [Full Text] [Related]  

  • 55. Autologous stem-cell transplantation for chronic myelogenous leukemia.
    Goldman JM
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):53-4. PubMed ID: 7901914
    [No Abstract]   [Full Text] [Related]  

  • 56. Is there a place for autologous bone marrow transplantation in chronic myeloid leukemia?
    Frassoni F; Carella AM
    Stem Cells; 1993 Oct; 11 Suppl 3():1-3. PubMed ID: 8298470
    [No Abstract]   [Full Text] [Related]  

  • 57. New perspectives with interferon alpha. The German CML study group experience.
    Hehlmann R; Ansari H; Adelberger V; Heinze B; Hossfeld K; Hochhaus A; Heimpel H
    Bone Marrow Transplant; 1994; 14 Suppl 3():S14-20. PubMed ID: 7697004
    [No Abstract]   [Full Text] [Related]  

  • 58. The management of chronic myeloid leukaemia--a case history.
    Sureda A; Hernández-Bronchud M
    Ann Oncol; 1997 Jan; 8(1):91-6. PubMed ID: 9093713
    [No Abstract]   [Full Text] [Related]  

  • 59. Chronic myelogenous leukemia: elements of conventional chemotherapy and an overview of autografting in the treatment of the chronic phase.
    Lauta VM
    Med Oncol; 2003; 20(2):95-116. PubMed ID: 12835513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autologous blood stem-cell transplantation and recombinant interferon alfa in chronic myeloid leukemia.
    Reiffers J; Montastruc M; Cahn JY; Souillet G; Troncy J; Leblond V; Caillot D; Troussard X; Marit G; Fabères C
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):51-2. PubMed ID: 8235709
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.